In the context of melanoma, the combination of anti‐PD1/anti‐PD‐L1 with non‐nanomaterials can also induce ferroptosis, enhancing tumour cell immunogenicity and improving immunotherapy efficacy. Here, PDCD1 is linked to neoplasm.